A drug-drug interaction trial in healthy female participants to investigate the effect of aprocitentan on combined hormonal contraceptives.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517224-19-00

Acronym

ID-080-111

Enrollment

Registered

2024-12-10

Start date

2025-01-06

Completion date

2025-02-21

Last updated

2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not applicable - healthy volunteer trial

None listed

Sex/Gender

All

Age

18 Years to No maximum

Czechia

None listed

Source: EU CTIS · Data processed: Feb 4, 2026